← Eichor
Condition: Hepatic Steatosis Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Hepatic Steatosis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Impact of Steatotic Liver Disease Associated With Metabolic Dysfunction (MASLD) on Frailty, Cognition, and Quality of Li
Phase N/A · 2 location(s) · Fundació Institut de Recerca de l'Hospital de la Santa Creu · NCT07652892Study for the Identification of a Score to Assess Intrapancreatic Fat Through Eco-Elastography and Its Correlation With
NA · 2 location(s) · Catholic University of the Sacred Heart · NCT06801769Effects of Peanut Consumption on Adults With Metabolic Associated Fatty Liver Disease
NA · 1 location(s) · Henry Ford Health System · NCT07646197Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly
NA · 1 location(s) · Phenomen Pharma · NCT07068191Determination of Pancreatic Steatosis Prevalence and Correlation With High-risk Cyst Features
NA · 1 location(s) · Chinese University of Hong Kong · NCT05334836A Study of Efimosfermin Alfa in Adults With Hepatic Impairment
Phase 1 · 3 location(s) · GlaxoSmithKline · NCT07358546Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
Phase 2 · 1 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT03884075Quantifying Hepatic Mitochondrial Fluxes in Humans
Phase 4 · 2 location(s) · The University of Texas Health Science Center at San Antonio · NCT05305287Evaluation of a New Ultrasound System for the Non-invasive Assessment of Liver Steatosis in MASLD/MASH Patients
NA · 3 location(s) · E-Scopics · NCT06661655The European NAFLD Registry
Phase N/A · 37 location(s) · Newcastle University · NCT04442334Human Models of Selective Insulin Resistance: Alpelisib, Part I
Phase 1 · 1 location(s) · Columbia University · NCT06354088EVOO and Metabolic Liver Health in MASLD
NA · 1 location(s) · Azienda Ospedaliera Specializzata in Gastroenterologia Saver · NCT07412444The Effects of Glucagon on Hepatic Metabolism in People With Type 2 Diabetes After Caloric Restriction
Phase 2 · 1 location(s) · Adrian Vella · NCT05499702SMART Diets for MASLD
Phase 2 · 1 location(s) · Michigan State University · NCT07459504Liver Steatosis in Pediatric CD Patients
Phase N/A · 2 location(s) · University of Palermo · NCT06206616Siemens Biomarker Multi-modality
NA · 1 location(s) · Duke University · NCT07495332Preoperative Ketogenic Diet for Reduction of Hepatic Steatosis
NA · 1 location(s) · Anton Skaro · NCT05884723Characterization of the Intrahepatic Inflammatory Microenvironment in Patients With Non-alcoholic Steatohepatitis
NA · 1 location(s) · Hospices Civils de Lyon · NCT06152250Effect of 4 Weeks of Oral D. Piger on Safety, Pharmacokinetics and Ethanol Metabolism in Overweight Individuals (2023)
Phase 1 · 1 location(s) · Max Nieuwdorp · NCT06502834Cold-induced Brown Fat Activation and Hepatic Steatosis
NA · 1 location(s) · Medical University of Vienna · NCT03811236Effect of Amino Acids on Hepatic Fat Content in Adolescents (AMINOS Study)
Phase 3 · 1 location(s) · University of Colorado, Denver · NCT05935826Depletion of Liver Fat in Type 2 Diabetes
NA · 1 location(s) · Rigshospitalet, Denmark · NCT06211556Efficacy of 12-week Daytime Restricted Eating on Hepatic Steatosis of Obesity
NA · 9 location(s) · Nantes University Hospital · NCT07378072Acute Exercise and Endogenous Glucose Production in Type 2 Diabetes: Implications for Glycemic Control and Treatment of
NA · 1 location(s) · AdventHealth Translational Research Institute · NCT06993454Effect of CoQ10 on the Outcome of MAFLD Patients
Phase 2 · 1 location(s) · Ain Shams University · NCT05984745Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study)
Phase 2 · 1 location(s) · Hudson Biotech · NCT07481734An Observational Study Evaluating Patients With Chronic Liver Diseases Associated With Hepatic Steatosis
Phase N/A · 1 location(s) · University of Copenhagen · NCT05335603Assessment of the Prevalence of Steatotic Liver Disease Associated With Metabolic Dysfunction in Patients With Heterozyg
Phase N/A · 3 location(s) · Nantes University Hospital · NCT06634160Quantitative Ultrasound(DeepUSFF) vs MRI-PDFF for Liver Fat Assessment in MASLD
NA · 2 location(s) · Seoul National University Hospital · NCT07192159Global Research Initiative for Patients Screening on MASH
Phase N/A · 13 location(s) · Julius Clinical · NCT05651724
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.